Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-25-090429

Chief Medical Officer sold 7,848 shares at $6.80 ($53,366)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Karlin Daniel Chief Medical Officer 2025-06-25 Sale 10b5-1 −7,848 $6.80 $53,366 438,329 D: show line 1 in the form
Open-market sales · 7,848 sh · avg $6.80 · $53,366
Loading xslF345X05/ownership.xml…